Biofarmaceutica clinical-stage che sviluppa terapie con cellule staminali per malattie scheletriche pediatriche rare
| Date | Round | Amount |
|---|---|---|
| Nov 2025 | Funding round Danish company BOOST Pharma raised €3M from Sound Bioventures, with Industrifonden and Karolinska Development, to advance the BT-101 stem cell therapy for osteogenesis imperfecta. | $3.5M |